n-(2-hydroxypropyl)methacrylamide has been researched along with Cancer of Pancreas in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckway, B; Ghandehari, H; Ray, A; Wang, Y | 1 |
1 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Cancer of Pancreas
Article | Year |
---|---|
In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery.
Topics: Acrylamides; Animals; Cell Line, Tumor; Deoxycytidine; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrogen-Ion Concentration; Indium Radioisotopes; Inhibitory Concentration 50; Mice; Molecular Targeted Therapy; Pancreatic Neoplasms; Polymers; Receptor, ErbB-2 | 2014 |